Stock Analysis of Gossamer Bio Inc (GOSS) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code GOSS
Close 0.520
Change 0.0001 / 0.0192 %
Volume 15761.44 K
Vol Change 15029.67 K / 2053.90 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthNeutral
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Gossamer Bio Inc
PE (TTM)

-242.30

Very Poor
Price / Book

2032.83

Very Poor
Price / Sales

6163.93

Very Poor
Piotroski F Score

3.0

Not Good
Market Cap

117656 K

Enterprise Value

294565 K

ROA (TTM)

-65.33

Very Poor
ROE (TTM)

-838.97

Very Poor
Net Margin (TTM)

-2543.93

Very Poor
Revenue

%

0
Net Profit

21.61 %

-179817.00 K
Debt to Equity

3.33

Very Poor
Altman Z Score

-6.17

Very Poor
Quick Ratio

0

Poor
Cash Ratio

5.74

Very Good


Highs/Lows of Gossamer Bio Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.515 0.990 % 2.10 % 0.64480.507717-Jun-2411-Jun-24
Two Week0.5805 10.40 % 3.59 % 0.64480.499317-Jun-2410-Jun-24
One Month0.694 25.06 % 3.20 % 0.72620.499320-May-2410-Jun-24
Three Month1.46 64.38 % 6.96 % 1.450.499318-Mar-2410-Jun-24
Six Months1.02 49.01 % 15.98 % 1.60.499307-Mar-2410-Jun-24
One year1.44 63.88 % 24.12 % 1.880.452520-Jul-2324-Oct-23
Two year6.69 92.23 % 48.94 % 11.9710.452527-Oct-2224-Oct-23
Five year21.09 97.53 % 89.41 % 2.530.452516-Feb-2324-Oct-23


Technical View of Gossamer Bio Inc
RSI

29.42

Mild Bullish
MACD

-0.061

Mild Bullish
ADX

36.56

Mild Bullish
Super Trend

0.656

Mild Bearish
Williams %R

-85.70

Mild Bullish
CCI

-42.10

Mild Bullish


EMA 5

0.523

Mild Bearish
EMA 15

0.560

Mild Bearish
EMA 50

0.711

Mild Bearish
EMA 100

0.828

Strong Bearish
SMA 100

0.933

Strong Bearish
SMA 200

0.868

Strong Bearish
SMA 5 / 20

0.518 / 0.578

Mild Bearish
SMA 15 / 50

0.554 / 0.702

Mild Bearish
SMA 50 / 200

0.702 / 0.868

Strong Bearish




Charts of Gossamer Bio Inc


Returns of Gossamer Bio Inc with Peers
Period / StockGOSSCRDFJUPWAHG
1 Week0.990%-9.49%59.21%-5.89%
1 Mth-25.06%-26.45%138.82%13.80%
3 Mth-64.38%-46.92%215.65%-20.00%
6mth-49.01%90.71%819.45%33.33%
1 Year-63.88%70.06%255.88%135.29%
2 Year-92.23%57.99%150.34%-29.20%
5 Years-97.53%1.91%--89.20%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Gossamer Bio Inc with Peers
Ratio / StockGOSSCRDFJUPWAHG
PE-242.30-2.90-5.03-6.93
P/B2032.831.5216.784.78
ROA-65.33-45.85-181.90-27.60
ROE-838.97-52.48-333.85-69.79
Debt To Equity3.330.00990.6034.26
Revenue0
% 		460000
19.17 % 		6196.74 K
115.44 % 		13181.56 K
108.86 %
Net Income-179817.00 K
21.61 % 		-40801.00 K
5.35 % 		-15223.03 K
45.83 % 		-13084.04 K
22.35 %


Technicals of Gossamer Bio Inc with Peers
Technical / StockGOSSCRDFJUPWAHG-
ADX36.5627.8749.5320.35
CMF-0.694-0.1190.348-0.208
MFI73.3817.0174.0024.76
RSI29.4224.5975.6343.12
MACD Abv SignalTrueFalseTrueFalse
Price Above 50 MAFalseFalseTrueFalse-
Price Above 200 MAFalseTrueTrueFalse-


About : Gossamer Bio Inc

Address : 3013 Science Park Road, San Diego, CA, United States, 92121
Tel : 858 684 1300
URL : https://www.gossamerbio.com
Code : GOSS, ISIN : US38341P1021, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 08_Feb_2019
Employee Count : 135

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)